Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedEnrollment status now indicates that the study is no longer enrolling; additional help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header formatting was adjusted while the page revision advanced to v3.6.0.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page revision tag was updated to v3.5.5, replacing the previous v3.5.4, indicating a minor page revision.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows a new revision label, v3.5.4, replacing the previous v3.5.3. This reflects a software/asset update and does not modify the study details or content presented on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting an interface or site release rather than a change to the clinical trial record content.SummaryDifference0.1%

- Check69 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.